Natural components use in ovarian cancer.

  • Unique Paper ID: 157279
  • Volume: 9
  • Issue: 6
  • PageNo: 488-494
  • Abstract:
  • Among all female reproductive cancers, ovarian cancer is the most common cause of mortality. The seventh most frequent cancer among women worldwide in 2018 was ovarian cancer. The many kinds of ovarian cancer exhibit a wide range of molecular and genetic abnormalities, as well as varying responses to treatments, which makes it difficult to develop a universal therapeutic approach. Additionally, ovarian cancer cells have a propensity to develop resistance to standard cancer treatments via a variety of ways. To find an effective cancer treatment, a number of components have been investigated, including cytokines, growth factors, proteases, adhesion molecules, coagulation factors, hormones, and apoptotic agents. According to research, phytochemicals offer strong potential anti-cancer capabilities against a variety of malignancies. One of the phytochemicals that is widely present in daily life is quercetinfoods.. Several forms of cancer, including breast, lung, nasopharyngeal, kidney, colorectal, prostate, pancreatic, and ovarian cancer, have been shown to be inhibited by quercetin, according to extensive research. There have been numerous in vitro and in vivo studies done to assess the cytotoxic potential of quercetin against ovarian cancer. Researchers believe quercetin might be a good candidate for ovarian cancer treatment because it is cytotoxic to cancer cells through a variety of mechanisms and does not harm healthy cells. It may also work well as an adjuvant agent when combined with other anti-cancer medications. As a result, we concentrated on the chemo-preventive and curative effects of quercetin for ovarian cancer in this review and outlined some of the most recent research into the potential molecular processes by which this natural substance inhibits this cancer.

Cite This Article

  • ISSN: 2349-6002
  • Volume: 9
  • Issue: 6
  • PageNo: 488-494

Natural components use in ovarian cancer.

Related Articles